It’s been a little more than three years now since the Toronto Raptors pulled off the surprise of the NBA draft, selecting Scottie Barnes with the No. 4 pick in 2021. It was a decision that ...
In Novartis’ favour is that there are plenty of other companies working on IgAN therapies, including Ionis/Roche’s antisense-based complement factor B therapy IONIS-FB-LRx, Omeros’ anti-MASP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback